CEN Biotech Pink Sheet Forecast - Naive Prediction
| CENBF Stock | USD 0.0001 0.00 0.00% |
The Naive Prediction forecasted value of CEN Biotech on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00000359 and the sum of the absolute errors of 0.0002. CEN Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of CEN Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 17th of January 2026 the relative strength index (rsi) of CEN Biotech's share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using CEN Biotech hype-based prediction, you can estimate the value of CEN Biotech from the perspective of CEN Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of CEN Biotech on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00000359 and the sum of the absolute errors of 0.0002. CEN Biotech after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CEN |
CEN Biotech Additional Predictive Modules
Most predictive techniques to examine CEN price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CEN using various technical indicators. When you analyze CEN charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
CEN Biotech Naive Prediction Price Forecast For the 18th of January 2026
Given 90 days horizon, the Naive Prediction forecasted value of CEN Biotech on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00000359, mean absolute percentage error of 0, and the sum of the absolute errors of 0.0002.Please note that although there have been many attempts to predict CEN Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that CEN Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
CEN Biotech Pink Sheet Forecast Pattern
| Backtest CEN Biotech | CEN Biotech Price Prediction | Buy or Sell Advice |
CEN Biotech Forecasted Value
In the context of forecasting CEN Biotech's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. CEN Biotech's downside and upside margins for the forecasting period are 0.000001 and 125.82, respectively. We have considered CEN Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of CEN Biotech pink sheet data series using in forecasting. Note that when a statistical model is used to represent CEN Biotech pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 97.1059 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 9.223372036854776E14 |
| SAE | Sum of the absolute errors | 2.0E-4 |
Predictive Modules for CEN Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CEN Biotech. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for CEN Biotech
For every potential investor in CEN, whether a beginner or expert, CEN Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. CEN Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in CEN. Basic forecasting techniques help filter out the noise by identifying CEN Biotech's price trends.CEN Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CEN Biotech pink sheet to make a market-neutral strategy. Peer analysis of CEN Biotech could also be used in its relative valuation, which is a method of valuing CEN Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
CEN Biotech Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of CEN Biotech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of CEN Biotech's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
CEN Biotech Market Strength Events
Market strength indicators help investors to evaluate how CEN Biotech pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CEN Biotech shares will generate the highest return on investment. By undertsting and applying CEN Biotech pink sheet market strength indicators, traders can identify CEN Biotech entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Currently Active Assets on Macroaxis
Other Information on Investing in CEN Pink Sheet
CEN Biotech financial ratios help investors to determine whether CEN Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CEN with respect to the benefits of owning CEN Biotech security.